Immunoglobulin G for patients with Necrotising Soft Tissue Infection

link.springer.com
immunoglobulin-g-for-patients-with-necrotising-soft-tissue-infection

The aim of the INSTINCT trial was to assess the effect of intravenous polyspecific immunoglobulin G (IVIG) compared with placebo on self-reported physical function in intensive care unit (ICU) patients with necrotising soft tissue infection (NSTI). In ICU patients with NSTI, we observed no apparent effects of adjuvant IVIG on self-reported physical functioning at 6 months.

Read More